Mehran F. Moghaddam

Mehran F. Moghaddam is the CEO of OROX BioSciences, Inc., where Mehran focuses on the discovery and development of small-molecule therapeutics for patients with fibrotic and oncological ailments. With a background in pharmacokinetics and drug metabolism, Mehran has held various leadership roles at Celgene Corporation and Pfizer Inc. Mehran also has postdoctoral training in lipid-mediated inflammatory diseases. Additionally, Mehran holds a Ph.D. in Medicinal Chemistry from Oregon State University and an Executive MBA from the University of Southern California.